Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NVO has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
NVO stock price ended at $79.83 on Friday, after losing-1.51%
The Novo Nordisk A/S stock price decreased by -1.51% on the last trading day (13 Jun 2025), dropping from 81.41 to 79.83. Throughout the last trading session, the stock experienced a fluctuation of 2.53% , ranging from a day low of $79.43 to a day high of 81.44. The price has declined in 3 of the last 10 days, resulting in a total change of 11.65% during this period. On the last day, trading volume decrease by -3.07M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 7.49M shares were traded, amounting to approximately 600.88M.
NVO Technical Signals
NVO(Novo Nordisk A/S Corp) has 3 buy signals and 4 sell signals now. The current trend is consolidation starting from 2025-05-29. The total price change during this trend is +14.93%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of NVO over the last 5 trading days is 807.23M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
NVO Moving Average Analysis
Novo Nordisk A/S's overall moving average trend leans more bullish as of Saturday, June 14, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $82.63347999999999, and $86.782. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $69.21052, and $65.062. A break-down below any of these levels will issue sell signals.
NVO Short Selling Analysis
The short sale ratio of Novo Nordisk A/S(NVO) as of 09 Jun 2025 is 19.54%, rising from last trading day. With increasing price from 74.63 to 75.46. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
4
Buy
3
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
9.274
Bullish
Momentum (10 days)
MOM_10 > 0
8.33
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
3.264
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
91.616
Bearish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
141.821
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
89.644
Bearish
Williams %R (14 days)
WILLR_14 > -20
-12.253
Bearish
NVO Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Novo Nordisk A/S(NVO), our algorithm predicts NVO's 1-month price at $74.49, with an -0.19%downwardshift. Using a similarity score up to 94.91%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Novo Nordisk A/S (NVO.N) stock, as of Sunday, June 8, 2025 , forecasts a -0.19% change over the next month, based on its high correlation with BP.N stock patterns. The similarity between their price movements over the analyzed periods is 94.91%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
NVO
No Data
BP
Down: -0.19%Similarity: 94.91%
Name
Similarity
Up/Down
BP.N
94.91%
-0.19%
GTN.N
94.83%
-1.41%
BRKL.O
94.61%
+6.93%
SAM.N
94.53%
-8.56%
NTB.N
94.19%
-1.21%
RBBN.O
93.95%
+39.56%
ENTX.O
93.92%
+25.64%
SHOP.N
93.83%
+5.28%
PW.A
93.75%
+1.09%
NTCT.O
93.74%
-4.41%
NVO Seasonality Analysis
Based on NVO's historical stock price data across all years, the probability of a positive return in June is53.33%, suggesting it maybe an ideal month to invest in NVO. In contrast,Apriloffers the highest probability of positive returns at71.43%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Novo Nordisk A/S (NVO.N) stock in April has the highest probability of a positive return (71.43%), while September has the lowest probability (30.77%).
Performance Seasonality
The chart shows Novo Nordisk A/S. (NVO)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Novo Nordisk A/S (NVO.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NVO has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Novo Nordisk A/S (NVO.N) stock in a year?
The radar chart shows that buying Novo Nordisk A/S (NVO.N) stock in April has the highest probability of a positive return (71.43%), while September has the lowest probability (30.77%).
How has Novo Nordisk A/S. (NVO)'s stock price performed over the past three years?
NVO's stock price rose by 53.00% in 2023,decreased by -15.76% in 2024, and went down by 8.79% in 2025.
Is NVO a buy based on overall technical signals summary?
NVO has 3 buy signals and 4 sell signals now. Overall the technical rating for NVO is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of NVO.
What is the trend of Novo Nordisk A/S (NVO)'s moving average?
Novo Nordisk A/S's overall moving average trend leans more bullish as of June 14 2025, with 1 negative signals and 3 positive signal.
What is price prediction for NVO stock next month?
The price prediction chart for Novo Nordisk A/S (NVO.N) stock, as of June 08 2025, forecasts a -0.19% change over the next month, based on its high correlation with BP stock patterns. The similarity between their price movements over the analyzed periods is 94.91%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for NVO Stock?
### **Price Prediction for NVO Stock in 2025**
Novo Nordisk (NVO) is expected to reach a price target of **$85.00** by the end of 2025. This prediction is based on the following factors:
1. **Fibonacci Levels**: The stock is currently trading near its resistance level of $78.47, with potential upside to $81.33 and $85.97.
2. **Technical Indicators**: The stock shows overbought signals on the RSI (85.31) and Stochastic Oscillator (%K at 91.23), suggesting short-term consolidation but medium-term bullish momentum.
3. **News Sentiment**: Recent news about activist investor involvement and a new Phase 3 trial for CagriSema could drive positive momentum.
What is price prediction 2030 for NVO Stock?
### **Price Prediction for NVO Stock by 2030**
- **Target Price**: $110 - $140
- **Reason**: Novo Nordisk's strong pipeline, including next-generation obesity drugs like CagriSema and oral semaglutide, positions it well in a growing market. However, competition from Eli Lilly and regulatory challenges could impact growth.